| 영문 | desensitization | 한글 | 민감소실, 탈민감 |
|---|---|---|---|
| 설명 | 1. 생체가 특이항원에 대하여 면역학적으로 반응이 없는 상태 또는 반응하지 않게 되는 과정. 2. 같은 방법이 정신적 알레르기에 대해서도 사용된다. 불안을 호소하는 심신장애에서는 처음 가장 약한 자극을 부여하여 그것을 극복하고, 점점 자극을 강하게 해 가는 계통적 탈감작법이 사용된다. 이 요법은 치과에서도 소아환자의 불안을 제거하기 위해 사용된다. 알레르기성 과민증이 그 원인 항원을 소량에서 점차적으로 증량 투여함에 의해 억제 혹은 경감되는 현상을 말한다. |
||
| DST | desensitization test; dexamethasone suppression test; dihydrostreptomycin; disproportionate septal t... |
|---|---|
| HCG, hCG | Human Chorionic Gonadotropin; 사람융모성성선자극호르몬 1. Placental Glycoprotein Hormone &nbs... |
| ICU | infant care unit; immunologic contact urticaria; intensive care unit; intermediate care unit |
| OILD | occupational immunologic lung disease |
| EMD | Eye Movement Desensitization |
|---|---|
| EMDR | Eye Movement Desensitization and Reprocessing |
| desensitization, immunologic | Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IgG, suppression of specific IgE, and an increase in suppressor T-cell activity. (12 Dec 1998) |
|---|
| allergy desensitization | Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and injections ( shots ) are usually required for 3-5 years. (12 Dec 1998) |
|---|---|
| heterologous desensitization | Stimulation by one agonist which leads to a broad pattern of unresponsiveness to further stimulation by a variety of other agonists. (05 Mar 2000) |
| homologous desensitization | Loss of sensitivity only to the class of agonist used to desensitise the tissue. (05 Mar 2000) |
| systematic desensitization | A type of behaviour therapy for eliminating phobias or anxieties: the patient and therapist construct a list of imagined scenes eliciting the phobia, ranked from least to most anxiety-producing; the patient then is trained in deep muscle relaxation, and is repeatedly asked to imagine himself in the presence of the least anxiety-producing scene on the list until he feels fully relaxed while doing so; the procedure is repeated for each scene on the list until the patient develops the capacity to feel relaxed with any of the anxiety-producing scenes; real life scenes are then substituted for the imagined scenes. Synonym: reciprocal inhibition. (05 Mar 2000) |
| desensitization | 1. The reduction or abolition of allergic sensitivity or reactions to the specific antigen (allergen). Synonym: ananaphylaxis, antianaphylaxis. 2. The act of removing an emotional complex. Synonym: hyposensitization. (05 Mar 2000) |
| desensitization, allergy | Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and shots (injections) are usually required for 3-5 years. (12 Dec 1998) |
| desensitization, psychologic | A behaviour therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli. (12 Dec 1998) |
| adjuvants, immunologic | Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (freund's adjuvant, bcg, corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (12 Dec 1998) |
| receptors, immunologic | Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behaviour of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. (12 Dec 1998) |
| graft enhancement, immunologic | The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. (12 Dec 1998) |
| monitoring, immunologic | Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumour antigen and other markers (often by radioimmunoassay), studies of cellular or humoral immunity in cancer aetiology, immunotherapy trials, etc. (12 Dec 1998) |
| contraception, immunologic | Contraceptive methods utilizing immunologic processes. (12 Dec 1998) |
| cytotoxicity, immunologic | The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitised T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. (12 Dec 1998) |
| cytotoxicity tests, immunologic | The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitised lymphocyte, an antibody, or complement. (12 Dec 1998) |
| suppressor factors, immunologic | Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-j) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. (12 Dec 1998) |
Synonyms : Immunologic Desensitization, Therapy, Hyposensitization, Allergen Immunotherapies, Desensitizations, Immunologic, Hyposensitization Therapies, Immunologic Desensitizations, Immunotherapies, Allergen, Therapies, Hyposensitization
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|